Triple receptor agonist
Retatrutide
40 mg
40 mg / 3 ml prefilled pen for subcutaneous use.
- Presentation
- 40 mg/3 ml prefilled pen
- Pharmaceutical form
- Solution for injection
- Route of administration
- Subcutaneous
- Storage
- 2 to 8 °C. Do not freeze. Protect from light.
For clinical, packaging or regulatory enquiries, contact our medical information team.
Make an enquiryProduct information
Overview
The 40 mg Retatrutide pen carries a higher concentration fill for longer titration cycles, packaged in the same deep navy carton architecture used across the OVO Pharmaceuticals peptide range.
Presentation details
- Extended titration range in one device
- Legible strength panel on all faces
- Cold chain validated packaging
Specification
- Active ingredient
- Retatrutide
- Class
- GIP/GLP 1/glucagon receptor agonist
- Fill volume
- 3 ml
- Device
- Multi-dose prefilled pen
- Pack
- 1 pen per carton
- Marking
- For single patient use only
